Prefrontal and Occipital Network Excitability Differences in Dementia with Lewy Bodies and Alzheimer's Disease

Background There is a great need in distinguishing Dementia with Lewy Body (DLB) from Alzheimer's disease (AD) and elucidating its pathophysiology. Transcranial magnetic stimulation (TMS) evoked potentials (TEPs) offer a non-invasive measure of neurophysiological alterations associated with underlying disease pathology. Methods A total of 39 participants were included: 12 DLB, 10 AD, and 17 age-matched healthy controls (HC). TEPs were measured in the dorsolateral prefrontal cortex (DLPFC), primary motor cortex (M1), and primary visual cortex (V1). Results Global mean field potential (GMFP) TEP (130-250 ms) showed a significant interaction of group and stimulation site ( p = .0101, ηp 2 = 0.175) with a significant group effect ( p = .0071, ηp 2 = 0.234), attributed to higher GMFP in DLB compared to AD and HC in response to V1 stimulation ( p = .001, p = .001, respectively). TEP amplitude corresponding to P60 displayed a significant group*stimulation site interaction ( p = .0037, ηp 2 = 0.202) arising from differences in DLPFC stimulation, between DLB compared to AD ( p = .0013) and HC ( p = .0032). DLPFC N45 presented a significant stimulation site effect not associated to a specific group in addition to DLPFC N45 amplitude being correlated to the UPDRS-III score (r = 0.9, p = .0002). A relative higher left over right DLPFC P30 amplitude was correlated with poorer MoCA scores in AD (r = −0.84, p = .002), as indicated by others before. Conclusions DLPFC may be a target for both diagnosis and assessment of severity of motor symptoms in DLB and cognitive impairment in AD. These results propose a promising method to non-invasively distinguish DLB from AD and monitor disease, based on DLPFC and V1 network characteristics.

Authors

Institutions

Publication Details

Journal
Clinical EEG and Neuroscience
Published
2026-05-21
DOI
https://doi.org/10.1177/15500594261452759
Primary Topic
Transcranial Magnetic Stimulation Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prefrontal and Occipital Network Excitability Differences in Dementia with Lewy Bodies and Alzheimer's Disease

Tamara Shiner, Noa Bregman, Hilla Fogel, Noa Zifman et al.
Clinical EEG and Neuroscience
Transcranial Magnetic Stimulation Studies
article

Prefrontal and Occipital Network Excitability Differences in Dementia with Lewy Bodies and Alzheimer's Disease

Tamara Shiner, Noa Bregman, Hilla Fogel, Noa Zifman, Eden Abulher, Inbal Maidan
article en

Abstract

Background There is a great need in distinguishing Dementia with Lewy Body (DLB) from Alzheimer's disease (AD) and elucidating its pathophysiology. Transcranial magnetic stimulation (TMS) evoked potentials (TEPs) offer a non-invasive measure of neurophysiological alterations associated with underlying disease pathology. Methods A total of 39 participants were included: 12 DLB, 10 AD, and 17 age-matched healthy controls (HC). TEPs were measured in the dorsolateral prefrontal cortex (DLPFC), primary motor cortex (M1), and primary visual cortex (V1). Results Global mean field potential (GMFP) TEP (130-250 ms) showed a significant interaction of group and stimulation site ( p = .0101, ηp 2 = 0.175) with a significant group effect ( p = .0071, ηp 2 = 0.234), attributed to higher GMFP in DLB compared to AD and HC in response to V1 stimulation ( p = .001, p = .001, respectively). TEP amplitude corresponding to P60 displayed a significant group*stimulation site interaction ( p = .0037, ηp 2 = 0.202) arising from differences in DLPFC stimulation, between DLB compared to AD ( p = .0013) and HC ( p = .0032). DLPFC N45 presented a significant stimulation site effect not associated to a specific group in addition to DLPFC N45 amplitude being correlated to the UPDRS-III score (r = 0.9, p = .0002). A relative higher left over right DLPFC P30 amplitude was correlated with poorer MoCA scores in AD (r = −0.84, p = .002), as indicated by others before. Conclusions DLPFC may be a target for both diagnosis and assessment of severity of motor symptoms in DLB and cognitive impairment in AD. These results propose a promising method to non-invasively distinguish DLB from AD and monitor disease, based on DLPFC and V1 network characteristics.

Clinical EEG and Neuroscience
Tel Aviv University (IL), Tel Aviv Sourasky Medical Center (IL), Quanterix (United States) (US)
No poverty
Openalex Percentile: Top 6%
Transcranial Magnetic Stimulation Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.